Hualan Biological Engineering Inc  

(Public, SHE:002007)   Watch this stock  
Find more results for SHE: 002007
+0.59 (2.06%)
Oct 23 - Close
SHE real-time data - Disclaimer
Currency in CNY
Range 28.70 - 29.28
52 week 27.18 - 37.73
Open 28.71
Vol. 15.92M
Mkt cap 27.23B
P/E 34.38
EPS 0.85
Shares 930.09M
Oct 20, 2017
Q3 2017 Hualan Biological Engineering Inc Earnings Release
Aug 21, 2017
Q2 2017 Hualan Biological Engineering Inc Earnings Release

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 28.43% 39.87%
Operating margin 32.63% 43.34%
EBITD margin - 48.23%
Return on average assets 15.31% 17.79%
Return on average equity 17.25% 19.82%
Employees 1,718 -
CDP Score - -


No.A1, Hualan Avenue
+86-373-3559989 (Phone)
+86-373-3559991 (Fax)

Website links


HUALAN BIOLOGICAL ENGINEERING, INC. is a China-based company principally engaged in the research, development, production and sales of blood products. It also produces vaccine products and biological engineering products. The Company's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The Company mainly operates its businesses in domestic markets.

Officers and directors

Kang An Chairman of the Board, General Manager
Age: 65
Junmin Xie Chief Financial Officer, Secretary of the Board
Age: 46
Bei Fan Executive Deputy General Manager, Director
Age: 42
Ruowen Pan Deputy General Manager, Director
Age: 45
Qiping Wang Deputy General Manager, Director
Age: 58
Xiaowei Ma Deputy General Manager
Age: 45
Baoxian Zhang Deputy General Manager
Age: 43
Ying An Director
Age: 56
Peitang Huang Independent Director
Age: 68
Dexin Li Independent Director
Age: 60